Andrew Cooper
About Andrew Cooper
Andy Cooper is the Chief Executive Officer of CluePoints, with a background in pharmacology and over two decades of experience in software solutions for clinical operations.
Andy Cooper, Chief Executive Officer
Andy Cooper is the Chief Executive Officer, bringing a wealth of experience to his role. He joined CluePoints in December 2022 and has a significant background in the software industry, particularly focused on supporting Clinical Operations, Clinical Data Management, and Pharmacovigilance. His leadership is grounded in decades of hands-on experience, ensuring strategic direction and operational excellence.
Andy Cooper's Education and Expertise
Andy Cooper holds a degree in Pharmacology from the University of Leeds, UK. His academic background includes a focus on data mining the human genome for undiscovered inwardly rectifying potassium channels during his final year. This academic foundation supports his expert understanding of the intersection between pharmacology and data science.
Professional Background of Andy Cooper
Andy Cooper has more than 20 years of experience working with software companies. His career has been dedicated to providing innovative solutions for global Clinical Operations, Clinical Data Management, and Pharmacovigilance business processes. His work emphasizes the importance of integrating software tools to tackle data challenges in drug development.
Andy Cooper's Passion for Software in Drug Development
Andy Cooper has a strong passion for applying software to solve data challenges in drug development. Throughout his career, he has focused on leveraging technological advancements to enhance clinical trial processes and improve data management systems. His approach underscores the pivotal role that software innovations play in advancing the field of pharmacology and clinical research.